dm+d
421412005
Refrigerated Storage
Orencia
Bristol-Myers Squibb Pharmaceuticals LtdBristol-Myers Squibb Pharmaceuticals Ltd
Orencia
Pre-filled syringe and pen
Contact Bristol-Myers Squibb Pharmaceuticals Ltd in all cases where deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
24 September 2021
London MI Service
Orencia
Bristol-Myers Squibb Pharmaceuticals LtdBristol-Myers Squibb Pharmaceuticals Ltd
Orencia
250mg powder for concentrate for solution for infusion
Contact Bristol-Myers Squibb Pharmaceuticals Ltd in all cases where deviation from the recommended storage conditions has occurred.Refer to the current BNF for company contact details.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
24 September 2021
London MI Service
Lactation Safety Information
See summary
Long half-life increases risk of accumulation in breastfed infants
Low levels anticipated in milk due to the drug's properties
No published evidence of safety
Avoid in preterm infants and neonates as large protein molecules may appear in colostrum
16 September 2020